Bortrac 2 mg Injection
Glno
Uses of Bortrac 2 mg Injection:
Multiple myeloma, Mantle-cell lymphoma
Composition of Bortrac 2 mg Injection:
Bortezomib 2mg
MRP:
₹
0
Inclusive of all Taxes
*Product images are for illustrative purposes only and may differ from the actual product.
Uses
Bortezomib is generally used in treatment of mantle-cell lymphoma and multiple myeloma
Side effects
- Anemia (low number of red blood cells)
- Constipation
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Diarrhoea
- Fatigue
- Fever
- Loss of appetite
- Low blood platelets
- Nausea
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Vomiting
How to use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
Bortezomib is an anti-cancer drug. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.
Frequently Asked Questions
Q. Is Bortezomib a chemotherapy/hormonal drug/ cytotoxic?
Bortezomib is not a hormone. It is a chemotherapy/ cytotoxic drug used in the treatment of cancers including multiple myeloma and mantle cell lymphoma
Q. How does Bortezomib work?
Bortezomib belongs to the class of drugs called a proteasome inhibitor. It acts by blocking the action of proteasome, and affects the growth of cancerous (actively growing) cells
Q. Is Bortezomib FDA approved?
Yes, Bortezomib is approved by FDA
Q. Is Bortezomib dialyzable?
Yes, Bortezomib is dialyzable
Q. Is Bortezomib toxic?
Bortezomib can cause toxic effects if not given in appropriate dose although not everybody gets them
Q. Does Bortezomib cause constipation?
Bortezomib may cause side effects such as constipation.
Bortezomib is not a hormone. It is a chemotherapy/ cytotoxic drug used in the treatment of cancers including multiple myeloma and mantle cell lymphoma
Q. How does Bortezomib work?
Bortezomib belongs to the class of drugs called a proteasome inhibitor. It acts by blocking the action of proteasome, and affects the growth of cancerous (actively growing) cells
Q. Is Bortezomib FDA approved?
Yes, Bortezomib is approved by FDA
Q. Is Bortezomib dialyzable?
Yes, Bortezomib is dialyzable
Q. Is Bortezomib toxic?
Bortezomib can cause toxic effects if not given in appropriate dose although not everybody gets them
Q. Does Bortezomib cause constipation?
Bortezomib may cause side effects such as constipation.
Expert Advice
- Before taking Bortezomib, consult your doctor if you have any of the following disease conditions: disease of liver, kidney, heart or infections like fever with rash or genital sores, diabetes, low number of red or white blood cells or bleeding problems.Drink plenty of fluids every day during your treatment with Bortezomib.Tell your doctor if you are or planning to become pregnant or are breastfeeding.Consult your doctor if you have signs of serious brain infection such as memory loss, trouble in thinking, difficulty with walking or loss of vision.Do not drive or operate machinery after taking Bortezomib as it may cause tiredness, dizziness, fainting or blurred vision.
Product Details
SKU: PC-922228
Product Description: Bortrac 2 mg Injection is manufactured by Glno
Packing: Vial
Condition: New
Sold by: Pulse Pharmacy India Pvt. Ltd.
Product Description: Bortrac 2 mg Injection is manufactured by Glno
Packing: Vial
Condition: New
Sold by: Pulse Pharmacy India Pvt. Ltd.
